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Implications for Nursing Care 
                       Sign & Symptoms 
Lynch Syndrome 
Raejeanne B. Nutter, BSN, RN, CCRN 
             Introduction 
Lynch Syndrome is a genetic mutation that can lead to 
cancer.  Identification and preventive screening is key to 
surviving and thriving with LS. 
Below is the recommendation for individuals with LS.   
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 United States, approximately has 140,000 new cases 
of colorectal cancer are diagnosed each year.  About 
three to five percent of these cancers are caused by 
Lynch syndrome  (U.S. National Library of Medicine, 
2013).   The significance of understanding genetics 
and genetic mutations and individual risk factors is 
imperative to preventative treatment and early 
detection 
U.S. National Library of Medicine, 2013. 
• Completing genetic family history screening (GFHS) 
questionnaires during initial family history survey (4).   
• Utilizing the GFHS questionnaire supports the identification of at-
risk individuals for Lynch Syndrome who would benefit from 
genetic evaluation and testing (4)  
• Serum (blood) Germline sequencing of the MMR genes remains 
the gold standard for confirming the causative gene mutation for 
Lynch Syndrome (5) 
• The questionnaire encompasses multiple testing and diagnostic 
criteria from Original Amsterdam Criteria, Revised Amsterdam 
Criteria(Amsterdam Criteria II), Original Bethesda Criteria, 
Revised Bethesda Guidelines (1) 
• People diagnosed with LS will need preventive screening and 
surgical procedures to reduce the incidence of a cancer diagnosis. 
• Addition screening and testing will need to be ordered for these 
patients including having a family discussion and being sent for 
their genetic counseling and potential testing.   
 
 
• Lynch syndrome (LS) runs in 
families as an autosomal 
dominant disease.  This means 
that if one parent carries a 
mutated Lynch syndrome gene, 
there is a 50 percent chance 
that the mutation will be 
passed on to each child. (8)  
This topic was chosen because  
I have Lynch Syndrome .   
• Lynch syndrome previously 
known as Hereditary Non-
polyposis colorectal cancer 
syndrome (HNPCC) (9).    
• Lynch syndrome the 
preponderance of an innate 
cancer syndrome, the most 
common cause of heritable 
colorectal cancer, and the only 
known heritable cause of 
endometrial cancer.  Lynch 
syndrome is associated with 
cancers of the ovary, stomach, 
urothelial tract, small bowel, 
less frequently, cancers of the 
brain (glioblastoma), biliary 
tract, pancreas, and prostate 
(3).  
                                                                                                                                     Otterbein University, Westerville, Ohio  
• The median age for diagnosis for Lynch Syndrome is between 44 and 61 in 
contrast to 66 years of age in sporadic cases of Colorectal Cancer (CRC) 
(Harrison & Handley, 2017).  
• Signs of LS include a genetic predisposition to many primary cancers in the same 
person or on one side of the family; these cancers may be the same or different 
types of cancers known to be genetically linked.  (Pasalodos-Sanchez, Howard, & 
Scotting, 2013).   
• Identification may also include some rare cancers clustered in a family, diagnosis 
younger than average age, a particular genetic ancestry (Pasalodos-Sanchez et al., 
2013)  Understanding the family tree or family pedigree for determining carrier of 
mutated genes.  
• Underlying Pathophysiology  
• Lynch Syndrome is confirmed by a mutation in one 
of several mismatch repair  (MMR) genes.(10) 
• DNA is the genetic material that embodies 
instructions for every chemical process in the body.  
As cells grow and divide, DNA is copied, and it is 
common for minor mistakes to occur. (8) 
• MMR normally responsible for correcting mistakes 
in the deoxyribonucleic acid (DNA) sequence. (8) 
• MMR genes include MLH1, MSH2, MSH6, PMS2 
or by a mutation in the EPCAM gene. (10)  
• EPCAM gene is not involved in DNA repair (2) 
•  The EPCAM gene has been shown to cause Lynch 
Syndrome by turning off its neighboring MSH2 
gene (2)  
• The errors preferentially accumulate in regions of 
the genome called microsatellites. 
•  Microsatellites are  areas where repeating of DNA 
sequences, in which one to a few nucleotides (e.g., 
adenine-, cytosine-, guanine-, or thymine-based 
DNA elements) are repeated”(3)  The linear 
sequence of DNA is symbolized by the first letter 
of the nucleotide base.  When describing 
nucleotides, the first letter is used for 
identification, adenine (A), cytosine (C), guanine 
(G), thymine (T). (3) 
•  Normal cells have mechanisms to recognize these 
mistakes and repair them.(8) but during DNA 
synthesis, mutations can occur in microsatellites 
causing misalignments  of the repetitive  
sequences.  (3) 
• However, people who inherit a mutated version of 
one of the genes associated with Lynch syndrome 
cannot repair these minor mistakes leading to 
permanent changes or mutations in the DNA 
sequences (8) 
• An accumulation  of such misalignments can lead 
to the cells becoming cancerous. (8) 
Significance of Pathophysiology  
Top symptoms  
80-99%   Have  the following 
• Abdominal pain 
• Colon cancer 
• Constipation,  
• Fatigue 
• Gastrointestinal hemorrhage, 
• Glioblastoma multiforme 
• Malabsorption, 
• Weight loss.  
 
 
National Institute of Health Genetic and rare 
disease center  [NIH & GARD], 2018). 
30-79%  
• Anxiety 
• Attention deficit hyperactivity disorder 
(ADHD) 
• death in early adulthood 
• death in infancy depression 
• Hypertonia 
• Increased intracranial pressure 
• Irritability  
• Migraine  
• Muscular hypotonia, Nausea and 
vomiting 
• Neoplasm of the rectum 
•  Seizures 
5 
Variable associated with LS  Recommendation  Screening/Testing 
 Colonoscopy 
 
Annually or biennial 
 
 
Starting at age 20-25 years or 2 – 
5 years before earliest CRC 
diagnosis in the family  
 
 Endometrial cancer Annually Pelvic exam, endometrial 
sampling starting 30-35 years 
 Ovarian cancer Annually Transvaginal ultrasound starting 
age 30-35 years  
 Prophylactic hysterectomy 
and oophorectomy  
Recommendation  Hysterectomy and bilateral 
salpingo-oophorectomy who have 
finished childbearing or 40 years 
 Gastric cancer Consideration for at risk  Esoghagogastroduodenoscopy 
with gastric biopsy of antrum at 
30-35 years 
 Small Intestinal cancer No routine screening 
recommended at this time 
 
 Cancers of the urinary 
tract 
Annually  Urinalysis starting at 30-35 years 
 Pancreatic cancer No routine screening 
recommended at this time 
 
 Breast and prostate cancer No special recommendations for 
LS 
Routine general population 
screening 
 Treatment/Prevention Colectomy and Aspirin  Colectomy with ileorectal 
anastomosis primary treatment 
for colon cancer or colon 
neoplasia not removable by 
endoscopy.  Aspirin treatment is 
growing but is not conclusive.  
 
